Overview

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.
Phase:
Phase 4
Details
Lead Sponsor:
UCB Pharma
Treatments:
Anticonvulsants
Lacosamide